Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

WNT Stimulation Dissociates a Frizzled 4 Inactive-State Complex with Gα12/13

E. Arthofer, B. Hot, J. Petersen, K. Strakova, S. Jäger, M. Grundmann, E. Kostenis, JS. Gutkind, G. Schulte,

. 2016 ; 90 (4) : 447-59. [pub] 20160725

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023829

Frizzleds (FZDs) are unconventional G protein-coupled receptors that belong to the class Frizzled. They are bound and activated by the Wingless/Int-1 lipoglycoprotein (WNT) family of secreted lipoglycoproteins. To date, mechanisms of signal initiation and FZD-G protein coupling remain poorly understood. Previously, we showed that FZD6 assembles with Gαi1/Gαq (but not with Gαs, Gαo and Ga12/13), and that these inactive-state complexes are dissociated by WNTs and regulated by the phosphoprotein Dishevelled (DVL). Here, we investigated the inactive-state assembly of heterotrimeric G proteins with FZD4, a receptor important in retinal vascular development and frequently mutated in Norrie disease or familial exudative vitreoretinopathy. Live-cell imaging experiments using fluorescence recovery after photobleaching show that human FZD4 assembles-in a DVL-independent manner-with Gα12/13 but not representatives of other heterotrimeric G protein subfamilies, such as Gαi1, Gαo, Gαs, and Gαq The FZD4-G protein complex dissociates upon stimulation with WNT-3A, WNT-5A, WNT-7A, and WNT-10B. In addition, WNT-induced dynamic mass redistribution changes in untransfected and, even more so, in FZD4 green fluorescent protein-transfected cells depend on Gα12/13 Furthermore, expression of FZD4 and Gα12 or Gα13 in human embryonic kidney 293 cells induces WNT-dependent membrane recruitment of p115-RHOGEF (RHO guanine nucleotide exchange factor, molecular weight 115 kDa), a direct target of Gα12/13 signaling, underlining the functionality of an FZD4-Gα12/13-RHO signaling axis. In summary, Gα12/13-mediated WNT/FZD4 signaling through p115-RHOGEF offers an intriguing and previously unappreciated mechanistic link of FZD4 signaling to cytoskeletal rearrangements and RHO signaling with implications for the regulation of angiogenesis during embryonic and tumor development.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023829
003      
CZ-PrNML
005      
20170908104724.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1124/mol.116.104919 $2 doi
035    __
$a (PubMed)27458145
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Arthofer, Elisa $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.). $7 gn_A_00009011
245    10
$a WNT Stimulation Dissociates a Frizzled 4 Inactive-State Complex with Gα12/13 / $c E. Arthofer, B. Hot, J. Petersen, K. Strakova, S. Jäger, M. Grundmann, E. Kostenis, JS. Gutkind, G. Schulte,
520    9_
$a Frizzleds (FZDs) are unconventional G protein-coupled receptors that belong to the class Frizzled. They are bound and activated by the Wingless/Int-1 lipoglycoprotein (WNT) family of secreted lipoglycoproteins. To date, mechanisms of signal initiation and FZD-G protein coupling remain poorly understood. Previously, we showed that FZD6 assembles with Gαi1/Gαq (but not with Gαs, Gαo and Ga12/13), and that these inactive-state complexes are dissociated by WNTs and regulated by the phosphoprotein Dishevelled (DVL). Here, we investigated the inactive-state assembly of heterotrimeric G proteins with FZD4, a receptor important in retinal vascular development and frequently mutated in Norrie disease or familial exudative vitreoretinopathy. Live-cell imaging experiments using fluorescence recovery after photobleaching show that human FZD4 assembles-in a DVL-independent manner-with Gα12/13 but not representatives of other heterotrimeric G protein subfamilies, such as Gαi1, Gαo, Gαs, and Gαq The FZD4-G protein complex dissociates upon stimulation with WNT-3A, WNT-5A, WNT-7A, and WNT-10B. In addition, WNT-induced dynamic mass redistribution changes in untransfected and, even more so, in FZD4 green fluorescent protein-transfected cells depend on Gα12/13 Furthermore, expression of FZD4 and Gα12 or Gα13 in human embryonic kidney 293 cells induces WNT-dependent membrane recruitment of p115-RHOGEF (RHO guanine nucleotide exchange factor, molecular weight 115 kDa), a direct target of Gα12/13 signaling, underlining the functionality of an FZD4-Gα12/13-RHO signaling axis. In summary, Gα12/13-mediated WNT/FZD4 signaling through p115-RHOGEF offers an intriguing and previously unappreciated mechanistic link of FZD4 signaling to cytoskeletal rearrangements and RHO signaling with implications for the regulation of angiogenesis during embryonic and tumor development.
650    _2
$a protein dishevelled $x metabolismus $7 D000072261
650    _2
$a FRAP $7 D036681
650    _2
$a rezonanční přenos fluorescenční energie $7 D031541
650    _2
$a frizzled receptory $x chemie $x metabolismus $7 D051157
650    _2
$a proteiny vázající GTP - alfa-podjednotky G12-G13 $x metabolismus $7 D044365
650    _2
$a zelené fluorescenční proteiny $x metabolismus $7 D049452
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a vazba proteinů $x účinky léků $7 D011485
650    _2
$a proteinové domény $7 D000072417
650    _2
$a faktory zaměňující Rho guanin nukleotidy $x metabolismus $7 D064067
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a proteiny Wnt $x farmakologie $7 D051153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hot, Belma $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Petersen, Julian $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Strakova, Katerina $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Jäger, Stefan $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Grundmann, Manuel $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Kostenis, Evi $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Gutkind, J Silvio $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.).
700    1_
$a Schulte, Gunnar $u Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A., B.H., J.P., K.S., S.J., G.S.); Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (E.A.); Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic (K.S., G.S.); Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany (M.G., E.K.); Department of Pharmacology, Moores Cancer Center, University of California, San Diego, La Jolla, California (J.S.G.) gunnar.schulte@ki.se.
773    0_
$w MED00003399 $t Molecular pharmacology $x 1521-0111 $g Roč. 90, č. 4 (2016), s. 447-59
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27458145 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170908105325 $b ABA008
999    __
$a ok $b bmc $g 1239510 $s 984742
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 90 $c 4 $d 447-59 $e 20160725 $i 1521-0111 $m Molecular pharmacology $n Mol Pharmacol $x MED00003399
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace